nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of superparamagnetic iron oxide (AMI-227) for 3D phase-contrast MR angiography
|
Tanimoto, Akihiro |
|
1998 |
5 |
S1 |
p. S113-S115 3 p. |
artikel |
2 |
Assessment of acute and reperfused myocardial ischemia using GdDTPA, GdDTPA-cascade-24-polymer and albumin-GdDTPA
|
Roberts, H.C. |
|
1998 |
5 |
S1 |
p. S31-S33 3 p. |
artikel |
3 |
Blood-Pool contrast agents for MRI: A critical evaluation
|
Koenig, Seymour H. |
|
1998 |
5 |
S1 |
p. S200-S205 6 p. |
artikel |
4 |
Can contrast media act as “Pseudoantigens”?
|
Lasser, Elliott C. |
|
1998 |
5 |
S1 |
p. S95-S98 4 p. |
artikel |
5 |
Clinical experience with AF0150 (Imagent US), a new ultrasound contrast agent
|
Pelura, Timothy J. |
|
1998 |
5 |
S1 |
p. S69-S71 3 p. |
artikel |
6 |
Clinical usefulness of iomeprol 400 mgl/mL in cardioangiography evaluation of patient discomfort and hemodynamic and ECG effects
|
Himi, Kazuhisa |
|
1998 |
5 |
S1 |
p. S54-S57 4 p. |
artikel |
7 |
Contrast-enhanced magnetic resonance angiography in the coronary and peripheral arteries
|
Saeed, Maythem |
|
1998 |
5 |
S1 |
p. S108-S112 5 p. |
artikel |
8 |
Contrast-enhanced MR angiography and first-pass renal perfusion imaging using MS-325, an intravascular contrast agent
|
Prasad, Pottumarthi V. |
|
1998 |
5 |
S1 |
p. S219-S222 4 p. |
artikel |
9 |
Contrast-enhanced MRI of focal liver lesions: Differentiation and detection of primary and secondary liver lesions using resovist-enhanced versus gadolinium-enhanced MRI in the same patient
|
Hammerstingl, Renate |
|
1998 |
5 |
S1 |
p. S75-S79 5 p. |
artikel |
10 |
Contrast enhancement of the liver in healthy male volunteers following intravenous administration of FP 736-04
|
Magnusson, Anders |
|
1998 |
5 |
S1 |
p. S9-S12 4 p. |
artikel |
11 |
Contrast-enhancement properties of irradiated normal lymph nodes: Initial experience with interstitially delivered iodinated nanoparticles
|
Wisner, Erik R. |
|
1998 |
5 |
S1 |
p. S180-S182 3 p. |
artikel |
12 |
Delayed adverse reaction of monomeric contrast media: Comparison of plain CT and enhanced CT
|
Munechika, H. |
|
1998 |
5 |
S1 |
p. S157-S158 2 p. |
artikel |
13 |
Delayed hypersensitivity to X-ray CM: Possible mechanisms and models
|
Speck, Ulrich |
|
1998 |
5 |
S1 |
p. S162-S165 4 p. |
artikel |
14 |
Development of a novel nonaromatic small-molecule MR contrast agent for the blood pool
|
Adzamli, Kofi |
|
1998 |
5 |
S1 |
p. S210-S213 4 p. |
artikel |
15 |
Diagnostic improvement of renal ultrasonography in humans after IV injection of perflenapent emulsion
|
Correas, Jean-Michel |
|
1998 |
5 |
S1 |
p. S185-S188 4 p. |
artikel |
16 |
Discussion for session 2
|
|
|
1998 |
5 |
S1 |
p. S28-S30 3 p. |
artikel |
17 |
Discussion for session 5
|
|
|
1998 |
5 |
S1 |
p. S72-S74 3 p. |
artikel |
18 |
Discussion for session 11
|
|
|
1998 |
5 |
S1 |
p. S156- 1 p. |
artikel |
19 |
Discussion for session 12
|
|
|
1998 |
5 |
S1 |
p. S166- 1 p. |
artikel |
20 |
Discussion for session 14
|
|
|
1998 |
5 |
S1 |
p. S199- 1 p. |
artikel |
21 |
Discussion for Session 15
|
|
|
1998 |
5 |
S1 |
p. S226-S227 2 p. |
artikel |
22 |
Discussion for session 9
|
|
|
1998 |
5 |
S1 |
p. S131-S132 2 p. |
artikel |
23 |
Discussion for session 4
|
|
|
1998 |
5 |
S1 |
p. S60-S62 3 p. |
artikel |
24 |
Discussion for session 7
|
|
|
1998 |
5 |
S1 |
p. S106-S107 2 p. |
artikel |
25 |
Discussion for session 13
|
|
|
1998 |
5 |
S1 |
p. S183-S184 2 p. |
artikel |
26 |
Discussion for session 10
|
|
|
1998 |
5 |
S1 |
p. S145-S146 2 p. |
artikel |
27 |
Discussion for session 6
|
|
|
1998 |
5 |
S1 |
p. S93-S94 2 p. |
artikel |
28 |
Discussion for session 16
|
|
|
1998 |
5 |
S1 |
p. S234-S235 2 p. |
artikel |
29 |
Discussion for session 17
|
|
|
1998 |
5 |
S1 |
p. S252-S253 2 p. |
artikel |
30 |
Discussion for session 3
|
|
|
1998 |
5 |
S1 |
p. S45-S46 2 p. |
artikel |
31 |
Drug eruption caused by nonionic iodinated X-ray contrast media
|
Akiyama, Masaki |
|
1998 |
5 |
S1 |
p. S159-S161 3 p. |
artikel |
32 |
Dynamic susceptibility contrast MR imaging for the evaluation of probable Alzheimer disease: A cost-effectiveness analysis
|
LaFrance, Norman D. |
|
1998 |
5 |
S1 |
p. S231-S233 3 p. |
artikel |
33 |
Dysprosium EOB DTPA: A new liver-specific contrast agent for computed tomography
|
Schuhmann-Giampieri, Gabriele |
|
1998 |
5 |
S1 |
p. S90-S92 3 p. |
artikel |
34 |
Effect of steroid pretreatment on contrast media-induced potassium release
|
Hayakawa, Katsumi |
|
1998 |
5 |
S1 |
p. S99-S101 3 p. |
artikel |
35 |
Efficacy and safety of liver-specific MRI contrast agents in rats with hepatitis and cirrhosis
|
Kato, Naoki |
|
1998 |
5 |
S1 |
p. S83-S85 3 p. |
artikel |
36 |
Efficacy of the hepatocyte-specific contrast medium FP 736-04 for CT in two models of experimental diffuse liver disease
|
Bergman, Antonina |
|
1998 |
5 |
S1 |
p. S13-S15 3 p. |
artikel |
37 |
Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent
|
Lanza, Gregory M. |
|
1998 |
5 |
S1 |
p. S173-S176 4 p. |
artikel |
38 |
Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion: Subjective and quantitative assessment
|
Albrecht, Thomas |
|
1998 |
5 |
S1 |
p. S195-S198 4 p. |
artikel |
39 |
Evaluation of Gd-DOTA-labeled dextran polymer as an intravascular MR contrast agent for myocardial perfusion
|
Casali, Cendrine |
|
1998 |
5 |
S1 |
p. S214-S218 5 p. |
artikel |
40 |
Evaluation of new thrombus-specific ultrasound contrast agent
|
Wright Jr, William H. |
|
1998 |
5 |
S1 |
p. S240-S242 3 p. |
artikel |
41 |
Evaluation of N,N′-bis-dimethyldiatrizoic acid analogs as liver imaging agents
|
Ranganathan, R.S. |
|
1998 |
5 |
S1 |
p. S23-S27 5 p. |
artikel |
42 |
Experimental hepatic dysfunction: Evaluation by MR imaging with Gd-EOB-DTPA
|
Murakami, Takamichi |
|
1998 |
5 |
S1 |
p. S80-S82 3 p. |
artikel |
43 |
Factors determining tumor contrast enhancement—Time curves
|
Dawson, Peter |
|
1998 |
5 |
S1 |
p. S228-S230 3 p. |
artikel |
44 |
Good resolution of contrast-enhanced MRA using USPIO on coronal plane acquisition: Experimental evaluation of time-of-flight effect using flow phantom and animal study
|
Tobe, Kimiko |
|
1998 |
5 |
S1 |
p. S116-S118 3 p. |
artikel |
45 |
High-resolution harmonic gray-scale imaging of normal and abnormal vessels and tissues in animals
|
Mattrey, Robert F. |
|
1998 |
5 |
S1 |
p. S63-S65 3 p. |
artikel |
46 |
Human pharmacokinetics and modeling of the concentration-attenuation relationship of a new liposomal liver-specific contrast agent for CT
|
Höglund, Peter |
|
1998 |
5 |
S1 |
p. S47-S48 2 p. |
artikel |
47 |
Influence of iotrolan on renal cortical and outer medullary blood flow in the rat
|
Liss, Per |
|
1998 |
5 |
S1 |
p. S123-S126 4 p. |
artikel |
48 |
Investigation of MR contrast media utility with the VX-2 tumor model
|
Runge, Val M. |
|
1998 |
5 |
S1 |
p. S34-S36 3 p. |
artikel |
49 |
Involvement of the lung in the histamine-releasing effects of iodinated contrast media
|
Corot, Claire |
|
1998 |
5 |
S1 |
p. S102-S105 4 p. |
artikel |
50 |
Kinetics of a novel blood pool agent (MP-2269) with persistent high relaxivity for MR angiography
|
Hofman, Mark B.M. |
|
1998 |
5 |
S1 |
p. S206-S209 4 p. |
artikel |
51 |
Lipid-based blood-pool CT imaging of the liver
|
Weichert, Jamey P. |
|
1998 |
5 |
S1 |
p. S16-S19 4 p. |
artikel |
52 |
Liver-tumor detection with ultrasound contrast: A blinded prospective study in rabbits
|
Girard, Michael S. |
|
1998 |
5 |
S1 |
p. S189-S191 3 p. |
artikel |
53 |
Macromolecular contrast media—enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade
|
Brasch, Robert C. |
|
1998 |
5 |
S1 |
p. S2-S5 4 p. |
artikel |
54 |
MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex)
|
Harisinghani, Mukesh G. |
|
1998 |
5 |
S1 |
p. S167-S169 3 p. |
artikel |
55 |
MR lymphography: Evidence of extravasation of superparamagnetic nanoparticles into the lymph
|
Clement, Olivier |
|
1998 |
5 |
S1 |
p. S170-S172 3 p. |
artikel |
56 |
MRX 501: A novel ultrasound contrast agent with therapeutic properties
|
Unger, Evan C. |
|
1998 |
5 |
S1 |
p. S247-S249 3 p. |
artikel |
57 |
Multicenter evaluation of the safety, tolerance, and efficacy of OptiMARK in magnetic resonance imaging of the brain and spine
|
Grossman, Robert |
|
1998 |
5 |
S1 |
p. S154-S155 2 p. |
artikel |
58 |
MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver
|
Spinazzi, Alberto |
|
1998 |
5 |
S1 |
p. S86-S89 4 p. |
artikel |
59 |
Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis
|
Small, W.C. |
|
1998 |
5 |
S1 |
p. S147-S150 4 p. |
artikel |
60 |
New liposomal liver-specific contrast agent for CT: First human phase I clinical trial assessing efficacy and safety
|
Leander, Peter |
|
1998 |
5 |
S1 |
p. S6-S9 4 p. |
artikel |
61 |
Optimizing imaging techniques to reduce errors in microvascular quantitation with macromolecular MR contrast agents
|
Roberts, T.P.L. |
|
1998 |
5 |
S1 |
p. S133-S136 4 p. |
artikel |
62 |
Pharmacokinetic and hemodynamic safety of two superparamagnetic agents, endorem and sinerem, in cirrhotic rats
|
Bonnemain, Bruno |
|
1998 |
5 |
S1 |
p. S151-S153 3 p. |
artikel |
63 |
Phase II, placebo-controlled trial of MRX115 (Aerosomes) for left heart and myocardial perfusion imaging
|
Pantely, George A. |
|
1998 |
5 |
S1 |
p. S66-S68 3 p. |
artikel |
64 |
Preface
|
Katayama, Hitoshi |
|
1998 |
5 |
S1 |
p. S1- 1 p. |
artikel |
65 |
Prospective randomized crossover pilot study of the safety and efficacy of carbon dioxide versus iodinated contrast for peripheral angiography
|
Oliva, Vincent |
|
1998 |
5 |
S1 |
p. S58-S59 2 p. |
artikel |
66 |
Receptor-mediated mechanisms in contrast medium—induced renal vasoconstriction
|
Drescher, Peter |
|
1998 |
5 |
S1 |
p. S119-S122 4 p. |
artikel |
67 |
Safety and pharmacokinetics of BR21, a liver-specific CT agent, in healthy volunteers
|
Spinazzi, Alberto |
|
1998 |
5 |
S1 |
p. S20-S22 3 p. |
artikel |
68 |
Safety of carbon dioxide as a contrast medium in cerebral angiography
|
Wilson, Alan J. |
|
1998 |
5 |
S1 |
p. S51-S53 3 p. |
artikel |
69 |
Safety of Levovist injection in patients undergoing exercise stress echocardiography: A placebo-controlled study
|
Wiggins, Jay R. |
|
1998 |
5 |
S1 |
p. S192-S194 3 p. |
artikel |
70 |
Selection of contrast medium for CT: What percentage of patients receiving CT needs nonionic contrast media (low-osmolarity contrast media)?
|
Michael Mu Huo Teng, |
|
1998 |
5 |
S1 |
p. S49-S50 2 p. |
artikel |
71 |
Simultaneous use of Gd-DTPA and spin-lock imaging: A phantom study
|
Ramadan, Usama Abo |
|
1998 |
5 |
S1 |
p. S141-S144 4 p. |
artikel |
72 |
Stimulated acoustic emission imaging (“Sono-scintigraphy”) with the ultrasound contrast agent Levovist: A reproducible Doppler ultrasound effect with potential clinical utility
|
Blomley, Martin |
|
1998 |
5 |
S1 |
p. S236-S239 4 p. |
artikel |
73 |
T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): Theory and experiment
|
Bulte, Jeff W.M. |
|
1998 |
5 |
S1 |
p. S137-S140 4 p. |
artikel |
74 |
Targeting of ultrasound contrast material: Selective imaging of microbubbles in vitro
|
Klibanov, Alexander L. |
|
1998 |
5 |
S1 |
p. S243-S246 4 p. |
artikel |
75 |
Toward necrotic cell fraction measurement by contrast-enhanced MRI of reperfused ischemically injured myocardium
|
Wendland, Michael F. |
|
1998 |
5 |
S1 |
p. S42-S44 3 p. |
artikel |
76 |
Use of intravascular contrast agents in MRI
|
Bjørnerud, Atle |
|
1998 |
5 |
S1 |
p. S223-S225 3 p. |
artikel |
77 |
Use of intravenous Optison contrast echocardiography reduces downstream resource use and enhances cost savings
|
Shaw, Leslee J. |
|
1998 |
5 |
S1 |
p. S250-S251 2 p. |
artikel |
78 |
Validation of intracoronary delivery of metalloporphyrin as an in vivo “Histochemical staining” for myocardial infarction with MR imaging
|
Yicheng, Ni |
|
1998 |
5 |
S1 |
p. S37-S41 5 p. |
artikel |
79 |
Visualizing renal anatomy and function with 1–10,000-nm radiocontrast agents
|
Wolf, Gerald L |
|
1998 |
5 |
S1 |
p. S127-S130 4 p. |
artikel |
80 |
X-ray phototherapy for solid tumors
|
Norman, Amos |
|
1998 |
5 |
S1 |
p. S177-S179 3 p. |
artikel |